Navigation Links
Reportlinker Adds China Pharmaceutical Market Overview
Date:12/8/2010

ty protection 93

State Intellectual Property Office (SIPO) 93

China provides 6 years of data exclusivity for pharmaceuticals, but it is not applied adequately in practice 94

Patent breakage 95

Case of Pfizer's Viagra fight in China 95

China's compulsory licensing policy is a cause for concern 96

Despite improvements China remains on the USTR Priority Watch List 96

Drug counterfeiting in China 97

China - Pricing and reimbursement 99

Pricing issues - continuing price cuts make China's business environment uncertain 99

The process for setting drug prices in China 100

Price cuts and the elimination of hospital mark-ups will make drugs more affordable 101

New Methods and Regulations on Drug Prices 103

Reimbursement issues in China 106

National Reimbursement Drug List (NRDL) 107

Essential Drug List (EDL) 108

Preferential purchasing of domestic drugs will hamper growth of foreign brands 109

Hospitals purchase drugs through a tendering system 109

Government crack down on overprescribing 110

Government initiatives to reduce reliance on hospital drug distribution have meant retail pharmacies are growing in importance 110

4. China - Pharmaceutical sales analysis 112

China - Key findings 112

Pharmaceutical market size 112

Leading therapy areas 112

Leading prescription pharmaceutical brands 112

Leading pharmaceutical companies 113

China - Pharmaceutical market size 114

China - Leading therapy areas 116

Infectious diseases drugs hold the largest share of the Chinese market value 118

Traditional Chinese medicines (TCMs) exhibited the strongest sales during 2005-09 119

China - Leading pharmaceutical brands 120

Shu Xue Ning achieved by far the highest sales in China in 2009 123

Ke Lin Ao 123

Plavix - FDA 'black box' warning may influence its sales in China
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Reportlinker Adds Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
2. Reportlinker Adds Gilead Sciences: PharmaVitae Profile
3. Reportlinker Adds Generics Market Outlook: 2015
4. Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents
5. Reportlinker Adds Monoclonal Antibodies: 2010
6. Reportlinker Adds Asia-Pacific Orthopedic Devices Market Outlook to 2016
7. Reportlinker Adds Astellas Pharma Inc.: PharmaVitae Profile
8. Reportlinker Adds Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020
9. Reportlinker Adds Global Generic Pharmaceuticals Industry Report
10. Reportlinker Adds Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
11. Reportlinker Adds Global Syringes (Disposable and Reusable) Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... N.J. , Sept. 17, 2014  Bayer HealthCare ... National Hemophilia Foundation,s 66 th Annual Meeting, which ... , D.C.  The data, which will be shared through ... treatment and patient care. Data will be presented in ... research into treatment modalities in hemophilia A patients, Bayer ...
(Date:9/17/2014)... EMERYVILLE, Calif. , Sept. 17, 2014 /PRNewswire/ ... newest data analytics solution that brings complete visibility ... minimize risks in an ever-evolving reimbursement landscape. Powered ... Integrity brings transparency to the critical point between ... operations impact revenue. The solution will improve revenue ...
(Date:9/17/2014)... 2014 Women everywhere know how frustrating a ... uncomfortable, they,re often also embarrassing and have a way ... Support ( http://ph-defense.com ) is a new, over-the-counter product ... homeopathic product. Odor, discharge, and discomfort ... infection. In many cases, the cause of such problems ...
Breaking Medicine Technology:Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3New Product from Vireo Systems: pH-D Feminine Health Support 2
... 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... to reprise key carfilzomib data presentations that were featured at ... San Diego, California. The teleconference will begin at ... Interested parties may access the teleconference and the presentation that ...
... /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... diagnostic ("IVD") company, responded today to the allegations raised ... dated December 6, 2011. The Company maintains that the ... "Report") concern matters which have long been disclosed in ...
Cached Medicine Technology:China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group 2China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group 3China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group 4China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group 5China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group 6
(Date:9/18/2014)... “ Francis Drake Eyewear ” was ... monthly Biz Report, which reviews and features the latest ... host of NewsWatch and technology expert, conducted the review ... can save users hundreds of dollars while still looking ... company creates fashion-forward glasses that are both stylish and ...
(Date:9/18/2014)... 2014 9Lover.com, an internationally well-known designer ... launched a big promotion for its maternity wedding outfits. ... buy discounted maternity wedding dresses on its ... to all global consumers. The company’s development manager believes ... of ladies delighted. The current special offer will last ...
(Date:9/17/2014)... global ablation technologies market is estimated to grow at ... mature markets (such as the U.S., Germany, France, and ... market in 2014, the Asia-Pacific region is poised to ... next five years.Factors such as increasing government initiatives for ... surgical centers, and the rising focus of international and ...
(Date:9/17/2014)... 18, 2014 IntimateRider, an inventor of ... , has announced that it has entered into a ... Mobility LLC. A primary reason for the deal is ... reach is global. About its sales potential, representatives at ... provide you with the latest products on the market ...
(Date:9/17/2014)... 2014 According to Centers for ... an estimated 173,285 sports- and recreation-related traumatic brain injuries, ... a blood test may be available to help doctors ... recovery will take. , In March of this ... found a way to test blood for a protein ...
Breaking Medicine News(10 mins):Health News:NewsWatch Recently Featured the Fashion-Forward Frames “Francis Drake Eyewear” on National Television 2Health News:Discounted Maternity Wedding Dresses For 2014 Introduced By 9Lover.com 2Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:9.6% CAGR for Ablation Technologies Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 2Health News:IntimateRider Announces All Terrain Medical & Mobility as Its New Dealer 3Health News:Breakthrough blood test will improve concussion diagnoses, treatment 2Health News:Breakthrough blood test will improve concussion diagnoses, treatment 3
... , , , SAN FRANCISCO, ... (ALCMI) today announced the execution of a letter of intent (LOI) ... on molecular diagnostic testing and banking of advanced-stage Lung Cancer tissues. ... http://www.newscom.com/cgi-bin/prnh/20090731/DC55399LOGO ) , , Specific ...
... Survivors of the childhood cancer neuroblastoma are eight times ... to be married, and more likely to have lower ... online July 31 in the Journal of the ... because minimal information exists on the long-term outcomes for ...
... , , TITUSVILLE, N.J., ... approved INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) extended-release injectable suspension for the ... the first once-monthly, long-acting, injectable atypical antipsychotic approved in the ... will market INVEGA SUSTENNA in the U.S. , , ...
... cells or other health conditions are spread, study finds , ... for low-risk cardiac surgery doesn,t appear to increase one,s chances ... , In the study of 1,062 people who required a ... than 80 percent of the patients were still alive a ...
... , GAINESVILLE, Fla., July 31 Sanofi-aventis US ... facial wrinkles in healthy patients in the USA. It offers results ... 7 years of experience with the product while abroad. It was ... Sanofi-aventis is a leading global pharmaceutical company. The FDA approval ...
... , , PHILADELPHIA, July 31 In ... middle class families still won,t be shielded from the crushing burden of ... erode, according to a study published this week in the New ... and David Grande, M.D., M.P.A, of the University of Pennsylvania,s ...
Cached Medicine News:Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 2Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 3Health News:Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc. 4Health News:Long-term health and social outcomes for neuroblastoma survivors 2Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 2Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 3Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 4Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 5Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 6Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 7Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 8Health News:FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia 9Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 2Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 3Health News:Post-Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families, PENN Analysis Shows 4
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: